JERUSALEM (AP) -- Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, on Thursday said it would lay off over a quarter of its workforce as part of a global restructuring meant to salvage its ailing business....

BING NEWS:
  • Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
    Teva Pharmaceuticals and Alvotech got the FDA’s greenlight for their biosimilar to Johnson & Johnson’s blockbuster Stelara, which will launch in the U.S. in February 2025.
    04/18/2024 - 2:38 am | View Link
  • Stelara biosimilar from Alvotech, Teva approved by FDA
    The companies plan to launch their copycat version of the blockbuster immune disease drug early next year, per a legal settlement with J&J.
    04/17/2024 - 5:11 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More World News